{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Laporte-Amargos J"],"funding":["Instituto de Salud Carlos III","Instituto de Salud Carlos III (ES)"],"pagination":["412"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC7236103"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["21(1)"],"pubmed_abstract":["<h4>Background</h4>Febrile neutropaenia (FN) is a very common complication in patients with haematological malignancies and is associated with considerable morbidity and mortality. Broad-spectrum antipseudomonal β-lactam antibiotics (BLA) are routinely used for the treatment of cancer patients with FN. However, the clinical efficacy of BLA may be diminished in these patients because they present with pathophysiological variations that compromise the pharmacokinetic (PK) parameters of these antibiotics. Optimised administration of BLA in prolonged infusions has demonstrated better clinical outcomes in critically ill patients. However, there is a paucity of data on the usefulness of this strategy in patients with FN. The aim of this study is to test the hypothesis that the administration of "],"journal":["Trials"],"pubmed_title":["Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients: protocol for a randomised, multicentre, open-label, superiority clinical trial (BEATLE)."],"pmcid":["PMC7236103"],"funding_grant_id":["PI17/01372"],"pubmed_authors":["Laporte-Amargos J","Tebe C","Videla S","Huguet M","Albasanz-Puig A","Carratala J","Padulles A","Arnan M","Puerta-Alcalde P","Carmona-Torre F","Sureda A","Parody R","Rigo-Bonnin R","Del Pozo JL","Batlle M","Munoz C","Garcia-Vidal C","Tubau F","Gudiol C"],"additional_accession":[]},"is_claimable":false,"name":"Efficacy of extended infusion of β-lactam antibiotics for the treatment of febrile neutropenia in haematologic patients: protocol for a randomised, multicentre, open-label, superiority clinical trial (BEATLE).","description":"<h4>Background</h4>Febrile neutropaenia (FN) is a very common complication in patients with haematological malignancies and is associated with considerable morbidity and mortality. Broad-spectrum antipseudomonal β-lactam antibiotics (BLA) are routinely used for the treatment of cancer patients with FN. However, the clinical efficacy of BLA may be diminished in these patients because they present with pathophysiological variations that compromise the pharmacokinetic (PK) parameters of these antibiotics. Optimised administration of BLA in prolonged infusions has demonstrated better clinical outcomes in critically ill patients. However, there is a paucity of data on the usefulness of this strategy in patients with FN. The aim of this study is to test the hypothesis that the administration of ","dates":{"release":"2020-01-01T00:00:00Z","publication":"2020 May","modification":"2026-04-18T07:16:06.251Z","creation":"2020-05-31T07:03:09Z"},"accession":"S-EPMC7236103","cross_references":{"pubmed":["32423462"],"doi":["10.1186/s13063-020-04323-0"]}}